CStone Pharma Grants Jiangsu Hengrui Rights to Investigational Cancer Drug in Greater China
CStone Pharma Grants Jiangsu Hengrui Rights to Investigational Cancer Drug in Greater China
中石製藥授予江蘇恆瑞在大中華區研究抗癌藥物的權利
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊